Xcell Therapeutics stock price
엑셀세라퓨틱스KRX:373110 · KOSDAQ · HealthcareToday's signals · No active technical signal.
Signal details →Xcell Therapeutics last closed at ₩1,039 (+5.91%) on 2026-10-02. Listed on KOSDAQ. Trailing 12 months PER is -1.5×. Its overall grade ranks 303 of 306 stocks in Healthcare.
About this company
Xcell Therapeutics last closed at ₩1,039 (+5.91%) on 2026-10-02. Listed on KOSDAQ.
Details →Reported results
Position in sector
Healthcare · Overall F · 303/306
Valuation grade D
Recent filings
DART · received recent list, not a complete filing history. Factual information, not investment advice.
Related stocks
- 삼성바이오로직스Customer
세포·유전자치료제 배양/공정용 소재·서비스 수요처로 연결 가능성이 큰 국내 바이오 CDMO
- 셀트리온Customer
바이오의약품 개발·생산 기업으로 세포배양 관련 제품의 잠재 고객
- SK바이오사이언스Customer
백신·바이오 생산 과정에서 배양 배지/공정 관련 제품 수요가 있는 주요 고객
About Xcell Therapeutics
- What technical signals does Xcell Therapeutics (373110) have?
- Xcell Therapeutics current technical signals: no active technical signal.
- Is Xcell Therapeutics a cup-and-handle pattern?
- No. Xcell Therapeutics has no valid Cup signal right now.
- What published figures are available for Xcell Therapeutics?
- Trailing 12 months PER: -1.5×. Latest quarter PBR: 3.97×. Dividend yield: 0.00%.
Like these rules? Backtest them.
Run this signal on this ticker in the free backtest builder — same window, no install.
Backtest this rule ↗Turn what you saw on this name into a strategy
Ask Q about Xcell Therapeutics, or open the plan table on the main site.
From the names you found to a trading rule
Tell Q about the stocks you found to place orders with your conditions.